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Abstract
Apoptosis (programmed cell death) is observed in vascular smooth muscle cells (VSMC) in atherosclerotic lesions and
stenotic lesions after injury, and modulates the cellularity of these lesions. It is recognized that cell growth and apoptosis are
two linked processes. Platelet-derived growth factor (PDGF) induces VSMC proliferation and migration in vitro. We studied
the effect of PDGF on apoptosis in VSMC. Cultured rat VSMC were treated with PDGF-AA or PDGF-BB. PDGF-BB
induced cell death in cultured VSMC in a time- and dose-dependent manner, but PDGF-AA did not. Gel electrophoresis of
genomic DNA and in situ DNA labeling confirmed that the cell death induced by PDGF-BB is apoptosis. PDGF-BB
treatment reduced bcl-2 mRNA and bcl-xl mRNA expression, in contrast, induced bcl-xs mRNA expression, linked with the
induction of apoptosis in cultured VSMC. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Apoptosis plays an important role in normal de-
velopment and many pathological processes. Induc-
tion of apoptosis is shown in a variety of diseases
including cancer, neurological disorders, and cardio-
vascular diseases [1^4]. Cell death is recognized in
atherosclerotic lesions and stenotic lesions after bal-
loon injury [5^7] in which excessive accumulation of
VSMC occurs. Apoptosis has also been observed in
the heart of spontaneously hypertensive rats [8] and
in the hypertrophied heart induced by pressure over-
load [9]. These observations indicate that cell growth
and apoptosis are two tightly linked processes in car-
diovascular diseases.
Platelet-derived growth factor (PDGF) has been
shown to be involved in the accumulation of
VSMC as chemoattractant after balloon injury of
the normal rat carotid artery in vivo [10]. PDGF-
BB induces proliferation and migration of VSMC
in vitro [11,12]. PDGF induces other important cel-
lular responses, including survival [13] and transfor-
mation [14]. In this study, we showed that PDGF-BB
induced apoptosis in cultured VSMC.
Apoptosis is regulated by a genetic program [15].
The Bcl-2 family is an important regulator of cell
death acting as a suppressor or an inducer [16]. In
transfection experiments, constitutive expression of
high levels of Bcl-2 is able to protect many cell types
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from apoptosis induced by exposure to a wide vari-
ety of adverse conditions and stimuli [16^19]. Several
additional proteins homologous to Bcl-2 have been
identi¢ed. One of these proteins, Bax, has the oppo-
site e¡ect to Bcl-2, and overexpression of Bax accel-
erates apoptotic death [20]. Bcl-x is another member
of the Bcl-2 family [21]. From a single bcl-x gene,
alternative splicing produces two mRNA species
with di¡erent sizes (707 base pairs (bp) and 518 bp
in the coding region). When the longer mRNA,
which translates Bcl-xl, is overexpressed in cells,
apoptosis is suppressed in a manner analogous to
the action of Bcl-2. In contrast, when the short
mRNA, which translates Bcl-xs, is overexpressed in
cells, apoptosis is induced in a manner analogous to
the action of Bax.
In recent studies, overexpression of c-Myc [22,23],
interleukin-1L [24], and antioxidant [25] induced
apoptosis in VSMC. However, the precise mecha-
nisms of apoptosis in VSMC have not been eluci-
dated. In this study, we report that the Bcl-2 family
regulates PDGF-BB-induced apoptosis in cultured
VSMC.
2. Materials and methods
2.1. Isolation and culture of vascular smooth muscle
cells
Rat VSMC (passage 3^10) were isolated from
thoracic aortas of 10-week-old Sprague-Dawley rats
(Charles River Japan, Kanagawa, Japan). Cells were
cultured in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) (Gibco BRL, Grand Island, NY, USA)
supplemented with 10% heat inactivated fetal calf
serum (FCS) and maintained at 37‡C with atmos-
pheric air and 5% CO2. After reaching con£uence,
the cells were transferred to DMEM containing 0.1%
FCS and cultured for 24 h, and then these cells were
treated in freshly prepared DMEM-0.1% FCS with-
out (as a control) or with PDGF (Upstate Biotech-
nology, Lake Placid, NY, USA) for an additional 96
h. PDGF were added to the culture medium at a
concentration of 100 ng/ml for PDGF-AA and
PDGF-BB. Cell morphology was examined by phase
contrast microscopy, and microphotographs were
taken during incubation with PDGF-AA or PDGF-
BB.
2.2. Flow cytometry and cell death
Cell death was determined by cell cycle analysis
using a £uorescence-activated cell sorter £ow cytom-
etry (FACS). VSMC were cultured in 12-well plates
in DMEM containing 10% FCS until con£uent den-
sity and then cultured in DMEM with 0.1% FCS for
24 h. The cells were treated with PDGF-BB at the
indicated concentrations. After treatment with
PDGF-BB for the indicated times, the cells were
trypsinized and stained with propidium iodide using
a Cycle Test Plus DNA Reagent Kit (Becton Dick-
inson, San Jose, CA, USA). The stained cells were
then subjected to £ow cytometry on the FACS
(FACSCalibur cyto£uorometer, Becton Dickinson)
and analyzed with CELL Quest software (Becton
Dickinson). Cell cycle analysis indicates that the cells
in G1, S and G2/M phases are alive and the cells in
pre-G1 phase (apoptotic phase) are dead. The per-
centage of cell death was calculated by the cell num-
ber in pre-G1 phase/the total cell numberU100.
2.3. Cell proliferation assay
Cell proliferation assay was performed using cell
proliferation reagent WST-1 (Boehringer Mannheim,
Mannheim, Germany). The cleavage of tetrazolium
salts, WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-
2H-5-tetrazolio]-1,3-benzene disulfonate) by mito-
chondrial dehydrogenases resulted in formazan in
viable cells, which was used for the quanti¢cation
of cell proliferation and cell viability by a colorimet-
ric assay. VSMC were seeded onto 96-well tissue
culture plates at a concentration of 2U103/well in
100 Wl of DMEM containing 10% FCS and cultured
for 48 h (20^30% con£uence). The cells were trans-
ferred to DMEM with 0.1% FCS and cultured for 24
h, and then treated with 100 ng/ml of PDGF-BB for
the indicated times. After treatment, 10 Wl of WST-1
were added to each well and the plate was incubated
for 1 h. Absorbance was measured at 450 nm with
reference wavelength at 690 nm by ELISA reader
(Multiskan Bichromatic, Labsystems, Helsinki, Fin-
land).
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2.4. DNA fragmentation analysis
Genomic DNA was isolated from VSMC after
treatment with PDGF-AA or PDGF-BB for 96 h.
Cells were lysed in 500 Wl DNA extraction solution
containing 20 mmol/l Tris-HCl, pH 7.4, 0.1 mol/l
NaCl, 5 mmol/l ethylenediaminetetraacetic acid
(EDTA), and 0.5% sodium dodecyl sulfate (SDS).
Cell lysates were incubated with 100 Wg/ml proteinase
K (Ambion, Austin, TX, USA) for 16 h at 37‡C.
After incubation, 500 Wl phenol was added to the
cell lysates, and mixed gently for 6 h. The mixture
was centrifuged at 15 000 rpm for 20 min, and the
upper aqueous phase was incubated with 5 Wg/ml
RNase for 1 h at 37‡C. After phenol/chloroform
(1:1, v/v) treatment, DNA was precipitated and dis-
solved in 10 mmol/l Tris-HCl and 1 mmol/l EDTA.
Finally, DNA was electrophoresed on 1.5% agarose
gel and stained with ethidium bromide.
2.5. In situ DNA labeling analysis
To detect DNA fragmentation in situ, nick end
labeling was performed using an ApoTag in situ
apoptosis detection kit (Oncor, Gaithersburg, MD,
USA). VSMC on a chamber slide were ¢xed with
0.25% glutaraldehyde and treated with 0.3% H2O2
for 30 min for inactivation of endogenous peroxi-
dase, and then incubated with digoxygenin-conju-
gated dUTP and deoxyribonucleotide transferase
for 1 h at 37‡C. Labeled DNA fragments were in-
cubated with antidigoxygenin monoclonal antibody
linked with peroxidase for 30 min at room temper-
ature. The chromogen 3,3P-diaminobenzidine (DAB)
(Wako Pure Chemical Industries, Osaka, Japan) was
used as substrate against peroxidase.
2.6. Isolation of cDNA for bcl-2, bax, and bcl-x
Total RNA was isolated from VSMC according to
the manufacturer’s instructions with Isogen (Nippon
Gene, Tokyo, Japan), and reverse-transcribed into
¢rst strand cDNA with oligo(dT) primers and avian
myeloblastosis virus reverse transcriptase (RT) using
a ¢rst strand cDNA synthesis kit (Clontech, Palo
Alto, CA, USA). Speci¢c sense and anti-sense pri-
mers for rat bcl-2 (sense: 5P-ATGGCGCAAGCCG-
GGAGAAC-3P ; anti-sense: 5P-TCACTTGTGGCC-
CAGGTATG-3P), bax (sense: 5P-GACACCTGAG-
CTGACCTTGG-3P ; anti-sense: 5P-GAGGAAGTC-
CAGTGTCCAGC-3P), and bcl-x (sense: 5P-
ATGTCTCAGAGCAACCGGGA-3P ; anti-sense:
5P-TCACTTCCGACTGAAGAGTG-3P) were syn-
thesized, and the ¢rst strand cDNA was subjected
to PCR ampli¢cation. PCR conditions were denatu-
ration at 94‡C for 45 s, annealing at 55‡C for 45 s
and elongation at 72‡C for 60 s, for 30 cycles. Am-
pli¢ed products were electrophoresed on 0.8% agar-
ose gel and puri¢ed. Puri¢ed DNA fragments were
subcloned into Bluescript KS(+) II plasmid vector
(Stratagene, La Jolla, CA, USA). Sequence analysis
was carried out on both strands.
2.7. Northern blot analysis
Total RNA isolated from VSMC was electropho-
resed on 1.0% agarose gel, and transferred to nylon
membranes (Highbond-N, Amersham, Bucks, UK).
Hybridization was performed using an ExpressHyb
solution (Clontech) according to the manufacturer’s
instructions. 32P-labeled cDNA probes were prepared
by the random primer method using a Prime-It II
random primer labeling kit (Stratagene). After wash-
ing, autoradiography was performed with X-ray ¢lm
(Hyper¢lm-MP, Amersham) with an intensifying
screen at 380‡C.
2.8. RT-PCR analysis of bcl-xl and bcl-xs mRNA
expression levels
To con¢rm the result by Northern blotting, the
RT-PCR method was used to measure the mRNA
expression level of bcl-xl or bcl-xs. Total RNA (1 Wg
each) from VSMC was reverse-transcribed into ¢rst
strand cDNA using oligo(dT) primers. The synthe-
sized ¢rst strand cDNA was subjected to 30 cycle
PCR ampli¢cation using the speci¢c primers encod-
ing rat bcl-x or rat GAPDH (sense: 5P-TGGAGTC-
TACTGGCGTCTTC-3P ; anti-sense: 5P-CAAAGG-
TGGAGGAATGGGAG-3P). PCR products were
electrophoresed on 1.5% agarose gel and visualized
by ethidium bromide staining. Ampli¢ed products
(bcl-xl : 707 bp, bcl-xs : 518 bp) were identi¢ed by
sequence analysis.
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3. Results
3.1. Cell death induced by PDGF-BB in 100%
con£uent VSMC
After incubation with PDGF-AA or PDGF-BB
for 96 h, morphological changes were examined by
phase contrast microscopy. Morphological changes
were not observed in cells treated with PDGF-AA
or in control cells (DMEM-0.1% FCS) (Fig. 1A,B).
In contrast, in PDGF-BB-treated cells, some cells
£oated, shrank and became round. Cell membrane
was blebbed and cytoplasm condensed (Fig. 1C).
Flow cytometric analysis demonstrated that cell
death occurred in PDGF-BB-treated cells in a time-
and dose-dependent manner (Fig. 2A,B).
Fig. 1. Apoptotic features of PDGF-BB-induced cell death.
Quiescent cultured VSMC were incubated with PDGF-AA or
PDGF-BB. After 96 h, cells were observed by phase-contrast
microscopy (original magni¢cation: U150). (A) Medium con-
taining 0.1% FCS alone as a control, (B) 100 ng/ml PDGF-AA,
(C) 100 ng/ml PDGF-BB.
Fig. 2. Time- and dose-dependent manner of induction of apop-
tosis by PDGF-BB. (A) VSMC were treated with 100 ng/ml of
PDGF-BB for the indicated times. (B) VSMC were treated with
PDGF-BB at the indicated concentrations for 96 h. After treat-
ment, cells were harvested for FACS analysis. The results repre-
sent the mean þ S.D. of three experiments.
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3.2. Cell proliferation induced by PDGF-BB in
non-con£uent VSMC
Although PDGF-BB induced cell death in VSMC
at 100% con£uence, it induced cell proliferation in
VSMC at 20^30% con£uence for 48 h as shown in
Fig. 3. This showed the usual proliferation e¡ect of
PDGF-BB on VSMC.
3.3. DNA fragmentation in VSMC undergoing
apoptosis
Apoptosis was con¢rmed by the characteristic lad-
dering pattern of nuclear chromatin fragmentation
on the electrophoresis of genomic DNA. Genomic
DNA from the control and PDGF-AA-treated cells
showed only high molecular DNA. In contrast, in-
ternucleosomal DNA (about 180 bp) appeared in
VSMC treated with PDGF-BB, indicating that apop-
tosis occurred in PDGF-BB-treated cells (Fig. 4A).
We also evaluated DNA fragmentation in situ, using
a nick end labeling method. Cells treated with
PDGF-BB showed positive nuclear staining with
DAB, mainly in rounded cells (Fig. 4B). Stained nu-
clei were condensed and fragmented.
3.4. Gene expression of the Bcl-2 family
To explore the possibility that the Bcl-2 family
plays a role in apoptosis in VSMC induced by
PDGF-BB, we quanti¢ed mRNA expression levels
of bcl-2, bax, bcl-xl, and bcl-xs by Northern blot
analysis. bcl-2 mRNA was clearly detected in control
Fig. 3. Cell proliferation by PDGF-BB in non-con£uent
VSMC. VSMC at 20^30% con£uence were treated with 100 ng/
ml of PDGF-BB for the indicated times. After treatment, cell
proliferation reagent, WST-1, was added to the medium. Ab-
sorbance was measured at 450 nm with reference wavelength at
690 nm by ELISA reader. The results represent the mean þ S.D.
of six experiments.
Fig. 4. (A) Gel electrophoresis of internucleosomal DNA fragmentation. Genomic DNA was extracted from VSMC treated with
PDGF-AA or PDGF-BB for 96 h. DNA (5 Wg/lane) was electrophoresed on 1.5% agarose gel. Lanes: 2, medium containing 0.1%
FCS alone as a control; 3, 100 ng/ml PDGF-AA; 4, 100 ng/ml PDGF-BB; 1 and 5, DNA size markers. (B) Identi¢cation of apop-
totic cells by in situ nick DNA end labeling. Quiescent VSMC were incubated with 100 ng/ml PDGF-BB for 72 h in a chamber slide
(Original magni¢cation: U400).
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VSMC, however, PDGF-BB at both 50 and 100 ng/
ml reduced bcl-2 mRNA expression to almost unde-
tectable levels (Fig. 5A). In contrast, there were no
apparent di¡erences in bax mRNA levels among the
three groups (Fig. 5A). In the analysis of bcl-x
mRNA levels, control cells expressed bcl-xl mRNA
but not bcl-xs mRNA. However, following treatment
with PDGF-BB, the bcl-xl mRNA level was drasti-
cally reduced, in contrast with the increase of the bcl-
xs mRNA level (Fig. 5A). Two forms of bcl-x
mRNA, bcl-xl and bcl-xs mRNA, were able to be
distinguished by Northern blot analysis. However,
since the two forms of bcl-x mRNA di¡er in size
by only 189 bp, bcl-xl and bcl-xs mRNA levels
were also determined using an RT-PCR method. In
control cells, both bcl-xl and bcl-xs mRNA could be
detected by the RT-PCR method, but bcl-xl mRNA
was expressed at a higher level than bcl-xs mRNA.
The bcl-xl mRNA level was reduced and the bcl-xs
mRNA level increased by induction of apoptosis by
PDGF-BB (Fig. 5B).
4. Discussion
It is widely accepted that apoptosis requires exog-
enous signals and endogenous genes which also lead
to di¡erentiation and proliferation [15,16]. Recent
studies have demonstrated that apoptosis is induced
in atherosclerotic lesions as well as restenotic lesions
after balloon injury [5^7]. In these lesions, migration
and proliferation of VSMC are promoted by diverse
growth factors including PDGF [10,11]. In the
present study, we showed that PDGF induced apop-
tosis in cultured VSMC, and analyzed the mecha-
nism of PDGF-induced apoptosis.
Kim et al. [26] used PDGF to induce apoptosis in
growth arrested murine ¢broblasts. In their study,
reverse growth arrest was induced in the G0 phase
by serum deprivation in murine ¢broblasts. The ad-
dition of PDGF to ¢broblasts can stimulate expres-
sion of c-myc, an immediate early response gene [27].
Activation of c-Myc expression leads to an accumu-
lation of p53 protein by stabilization in quiescent
¢broblasts [28]. The accumulation of c-Myc and/or
p53 can induce apoptosis in ¢broblasts [28^30].
From these observations, they speculated that c-
Myc and p53 are key factors in initiating apoptosis
in murine ¢broblasts. In our experiments, since con-
£uent VSMC were cultured in 0.1% FCS for 24 h
and then cell death was induced by PDGF-BB, c-
Myc and/or p53 may be involved in apoptosis in
VSMC as well as in ¢broblasts [26]. The di¡erence
between our study and their study is the cell con£u-
ence on PDGF treatment. They treated the ¢bro-
blasts at 10% con£uence with PDGF to induce apop-
tosis. We also treated VSMC with PDGF-BB before
reaching con£uence (20^30% con£uence). PDGF-BB
induced cell proliferation for 48 h and did not induce
apoptosis for 96 h. This result strongly indicates that
Fig. 5. E¡ects of PDGF-BB-induced apoptosis on bcl-2, bax
and bcl-x mRNA expression in VSMC. (A) Northern blot anal-
ysis shows bands of bcl-2, bax, bcl-x and GAPDH mRNA
from VSMC treated with medium containing 0.1% FCS alone
as a control or 50 or 100 ng/ml PDGF-BB. Results are repre-
sentative of three experiments. (B) E¡ects of PDGF-BB-induced
apoptosis on bcl-xl and bcl-xs mRNA by the RT-PCR method.
Agarose gel electrophoresis shows RT-PCR products using bcl-
x or GAPDH speci¢c primers from VSMC treated with me-
dium containing 0.1% FCS alone as control (lanes 2 and 6), 50
ng/ml PDGF-BB (lanes 3 and 7) or 100 ng/ml PDGF-BB (lanes
4 and 8) for 96 h. Lanes 1 and 5 show DNA size markers.
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cell density at 100% con£uence is one of the essential
factors for induction of apoptosis in VSMC. Cell-cell
contact (contact inhibition) leads to cell cycle arrest
[31]. Contact inhibition may be a critical factor in
PDGF-BB induced apoptosis in VSMC.
We demonstrated that apoptosis in VSMC was
able to be induced by PDGF-BB but not PDGF-
AA. We could detect the expression of PDGF-L re-
ceptor, but not PDGF-K receptor, by Northern blot
analysis in VSMC derived from Sprague-Dawley rats
(data not shown). This ¢nding is consistent with the
report by Kitami et al. [32]. They demonstrated that
VSMC derived from normotensive Wistar Kyoto rats
expressed PDGF-L receptor but not PDGF-K recep-
tor. PDGF-AA speci¢cally binds to the PDGF-K
receptor but does not bind to the PDGF-L receptor,
whereas PDGF-BB binds to both PDGF-K and
PDGF-L receptors [33,34]. These observations indi-
cate that PDGF-BB induces an apoptotic signal in
VSMC speci¢cally via PDGF-L receptor. The failure
of PDGF-AA to induce apoptosis in VSMC may be
due to the absence of the appropriate receptor. Inui
et al. [35] reported di¡erences in signal transduction
between PDGF-K and PDGF-L receptors in VSMC.
PDGF-BB strongly induced both protein and DNA
synthesis in VSMC, whereas PDGF-AA induced
only protein synthesis even if they used the VSMC
with highly expressed PDGF-K receptor. In VSMC,
PDGF-BB acts as a potent mitogen but PDGF-AA
does not in vitro [36]. The induction of apoptosis in
VSMC by PDGF-BB may depend on its mitogenic
activity.
The bcl-2 protooncogene was originally identi¢ed
as a transcriptional factor with the t(14:18) chromo-
somal translocation found in follicular lymphomas
[37]. Bcl-2 promotes survival under apoptotic stimu-
lus in various cells including hematopoietic cells [17],
neurons [19], endothelial cells [38] and cultured
VSMC [39]. Nishio et al. [39] used oxysterols, 7-ke-
tocholesterol or 25-hydroxycholesterol to induce
apoptosis in rabbit VSMC. Exposure to oxysterols
decreased the expression of Bcl-2 in VSMC under-
going apoptosis. In our study, the bcl-2 mRNA level
was decreased by induction of apoptosis in VSMC.
This observation is in agreement with the report by
Nishio et al. [39] as well as with previous studies
demonstrating prevention of apoptosis in bcl-2-trans-
fected cells [17^19].
Several novel proteins homologous to Bcl-2 have
been isolated. Bax has been identi¢ed as a Bcl-2-as-
sociated protein, and it has been shown that its over-
expression accelerates apoptotic death induced by
cytokine deprivation in an interleukin-3-dependent
cell line [20]. The ratio of the expression level of
Bcl-2 to Bax determines survival or death after an
apoptotic stimulus. When Bcl-2 is in excess, cells are
protected from death. On the other hand, when Bax
is in excess, cells are susceptible to apoptosis [20]. In
our study, the induction of apoptosis by PDGF-BB
did not a¡ect the bax mRNA level but reduced the
bcl-2 mRNA level, resulting in a shift to a relatively
higher bax mRNA level than bcl-2 mRNA level.
Bcl-x has been identi¢ed as a Bcl-2 homolog. By
alternative splicing, two mRNAs that di¡er in size by
189 nucleotides are transcribed from a single gene
bcl-x [21]. Sedlak et al. [40] have reported that Bax
is dimerized with Bcl-xl and speculated that a change
in the ratio of Bcl-2 and Bcl-xl to Bax and Bcl-xs
plays a predominant role in determining either sur-
vival (higher Bcl-2 and Bcl-xl expression) or death
(higher Bax and Bcl-xs expression). We further ex-
amined changes in bcl-x mRNA levels after the
apoptotic stimulus of PDGF-BB. In control cells, a
higher level of bcl-xl mRNA than of bcl-xs mRNA
was expressed. However, following treatment with
PDGF-BB, bcl-xl mRNA was decreased and bcl-xs
mRNA was increased. Switching from bcl-xl to bcl-
xs mRNA resulted in higher levels of bax and bcl-xs
mRNA than of bcl-2 and bcl-xl mRNA. The in-
creased relative expression ratio of bax and bcl-xs
mRNA may be a critical factor in induction of apop-
tosis in VSMC.
Perlman et al. [41] reported that medial VSMC in
balloon-injured rat carotid arteries were induced
apoptosis and the induction of apoptosis coincided
with a marked downregulation of Bcl-x (= Bcl-xl ;
they said that bcl-x confers protection from apopto-
sis in their study) expression. They also showed no
change in Bax expression in apoptotic VSMC. It is
not clear what regulates Bcl-x expression in VSMC
in balloon-injured arteries. However, their results are
in agreement with our results that the Bcl-2 family
regulates apoptosis in VSMC. PDGF may regulate
Bcl-2 family expression and apoptosis in VSMC in
balloon-injured arteries.
In conclusion, PDGF-BB induced apoptosis in cul-
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tured VSMC. The induction of apoptosis in VSMC
may be linked with a shift of the ratio of bcl-2 to bax
mRNA as well as bcl-xl to bcl-xs mRNA. These
results provide a great insight into the mechanism
of apoptosis in VSMC.
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